From: Application of molecular dynamics simulation in self-assembled cancer nanomedicine
Material composition | Composition shape | Simulation software | Force field | Treatment | Tumor types | Ref |
---|---|---|---|---|---|---|
Doxorubicin, Chitosan | chain | GROMACS | AMBER (GAFF) | Chemotherapy | --- | [66] |
Estrogen-related receptor α | Spiral | AMBER | ff14SB | Chemotherapy | --- | [67] |
Triazine-morpholino derivatives | Chain | AMBER | AMBER7FF9 | Chemotherapy | Breast cancer | [68] |
Genistein, AR endogenous agonist DHT | Spiral chain | GROMACS | OPLS-AA | Chemotherapy | Prostate cancer | [69] |
Fullerenes, gamma-cyclodextrin; inclusion complexes | Ring | Material Studio | CVFF(Consistent Valence-Force Field) | PDT | --- | [70] |
Levonorgestrel | Spiral chain | GROMACS | AMBER03 | Chemotherapy | Breast cancer | [71] |
Mammalian target of rapamycin | Chain | GROMACS | AMBER7FF99 | Chemotherapy | Lung cancer | [72] |
DOX, PAX | Nanotube | GROMACS | OPLS-AA | Chemotherapy | Lung cancer, breast cancer | [73] |
Anodic aluminum oxide, tantalum nitride-coated Si | Nanodot array | GROMACS | --- | Chemotherapy | --- | [74] |
Catalase-like RuO2@BSA@IR-808-Br2(RBIR) nanozyme | Nanotube | GROMACS | --- | PTT PDT | Breast cancer | [75] |
HCPT/Ce6 NRs | Nanorod | GROMACS | GROMOS53A6 | PDT | Breast cancer | [76] |
Epidermal growth factor receptor | Chain | AMBER | GAFF(Generation Amber-Force Field) | Chemotherapy | Lung cancer | [77] |
styrylquinolines | Chain | NAMD | CHARMM27 | Chemotherapy | --- | [78] |
Hsp90 C-terminal domain inhibitors | Chain | NAMD | CHARMM22 | Chemotherapy | --- | [79] |
SN38, trolox, succinic acid linker | Nanoparticles | GROMACS | OPLS-AA | Chemotherapy | Colorectal cancer | [80] |
TH peptides | Cyclic peptide | GROMACS | AMBER, OPLS-AA | Chemotherapy | Brain tumor | [81] |
Pure drug nanoa-ssemblies | Nanoparticles | GROMACS | --- | PTT, PDT | --- | [11] |
Daunorubicin, Etoposide | Nanotube | Gromacs5 | CHARMM27 | Chemotherapy | --- | [82] |
DOX, Aluminum Hydroxide | Nanosheet | LAMMPS | CHARMM27 | Chemotherapy | Melanoma | [83] |
Cu (II)-Schiff base complexes | Nanoparticles | AutoDock4 | --- | Chemotherapy | Human erythroleukemia cancer | [84] |
Aptamer -receptor | Nanoparticles | GROMACS | CHARMM | Chemotherapy | Breast cancer | [9] |
Adriamycin, chitosan, graphene | Nanosheet | GROMACS 5.0.7 | --- | Chemotherapy | --- | [85] |
P2Y1R receptor - indoline-4 carbonitrile HIC | Spiral chain | GROOMACS 4.6 | GROMOS | Chemotherapy | Prostate cancer | [86] |
HDAC inhibitors | Nanoparticles | NAMD | CHARMM | Chemotherapy | Prostate cancer | [87] |
DOX, carbon nanotubes | Nanotube | AMBER | CHARMM36 | Chemotherapy | --- | [88] |
DOX, black phosphorus | Nanosheet | GROMACS | CHARMM | Chemotherapy | --- | [89] |
Selective estrogen receptor downregulators(SERDs) | Reticular | AMBERTOOLS | --- | Chemotherapy | Breast cancer | [90] |
FPTT | --- | GROMACS | OPLS | Chemotherapy | Breast cancer | [91] |
RET kinase | Crystal, structure | AMBER18 | AMBER | Chemotherapy | Thyroid cancer | [92] |
MTORC1, arginine analogues | --- | AMBER16 | GAFF/ff144SB | Chemotherapy | Lung cancer | [93] |
Au NP, Panobinostat | Nanoparticles | AMBER19 | --- | Chemotherapy | --- | [94] |
SERDs | --- | AMBERTPPLS14 | AMBER | Chemotherapy | Breast cancer | [95] |